Agilent Technologies A Life Sciences and Diagnostics Markets — Depreciation

Other segment segments

Agilent CrossLab

$14M0.0%

Applied Markets

$7M+16.7%

Similar metrics at other companies

DHRLife Sciences — Depreciation

$48M+6.7%

ASHLife Sciences — Depreciation

$9M-59.1%

RVTYLife Sciences — Depreciation

$9.91M+37.9%

PTCTLife Science — Depreciation

$3.81M+10.1%

GLW

GLWLife Sciences and Emerging Growth Businesses — Depreciation

$26M-10.3%

TMOLife Sciences Solutions — Depreciation of property, plant and equipment

$70M+18.6%

Other financials

Income statement

See full

Revenue$1.8B+10.0%

Gross profit$990.0M+14.3%

Operating income$399.0M+33.0%

Net income$339.0M+57.7%

EPS (diluted)$1.20+60.0%

Balance sheet

See full

Cash & equivalents$1.8B+21.5%

Total debt$3.5B-3.9%

Total equity$7.1B+16.1%

Total assets$13.1B+7.5%

Cash flow

See full

Operating cash flow$277.0M+25.3%

CapEx$76.0M-33.3%

Free cash flow$201.0M+87.9%

Valuation

See full

Market cap$38.41B+15.0%

Enterprise value$40.15B+12.7%

P/E27.2×-1.5×

P/S5.3×+0.3×

Profitability

See full

Gross margin52.7%-0.6pp

Operating margin21.5%+0.1pp

Net margin19.6%+2.0pp

FCF margin15%-2.9pp

Returns & leverage

See full

Return on equity21.3%+2.4pp

Debt / equity0.5×-0.1×

Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's life sciences and diagnostics markets — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agilent Technologies's life sciences and diagnostics markets — depreciation?: Agilent Technologies (A) reported life sciences and diagnostics markets — depreciation of $26M in Q1 2026.
How has Agilent Technologies's life sciences and diagnostics markets — depreciation changed year-over-year?: Agilent Technologies's life sciences and diagnostics markets — depreciation increased by 8.3% year-over-year, from $24M to $26M.
What does life sciences and diagnostics markets — depreciation mean?: This is the systematic allocation of the cost of tangible assets, such as manufacturing equipment and laboratory facilities, over their useful lives. It reflects the wear and tear and obsolescence of the capital base used to generate segment revenue.